In January, J&J paused the heart device, citing an abundance of caution as it investigated four reported stroke events. Varipulse, which uses a pulsed field ablation technique to treat certain ...

Johnson & Johnson’s halt of U.S. sales of a new heart-rhythm device due to safety concerns is hobbling a major strategic push by the company into one of the industry’s fastest-growing markets.

In developing programming and production for Nassau Paradise Island Wine & Food Festival, Atlantis Paradise Island is joined for the second year by Lee Brian Schrager, founder of South Beach Wine & ...

Kentucky senior outside linebacker JJ Weaver was named the eighth annual ... by then-head athletic trainer Gabe Amponsah and a timely heart-to-heart talk with head coach Mark Stoops, who could ...

"TheGamersJoint brings you the latest gaming news, reviews, and in-depth discussions about all your favorite video games.

Dr. Jeremy London is a heart surgeon and a heart attack survivor. He operates on diseased hearts, but like many people, he ignored his own symptoms of a coronary artery blockage until it became an ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

DEADLINE: Emilia Perez has suffered from the resurfacing of polarizing social media posts by the actress who played the title ...

(Reuters) – Johnson & Johnson said on Friday it has resumed the limited market release of its Varipulse heart device in the United States after an investigation found the devices operate as intended.

Feb. 11, 2025 — Patients aged between 50 to 70 years with a mechanical heart valve replacement had better long-term survival compared to those with a biological valve, new research has ...

Business Day TV Spoke to Faheema Adia from Momentum Securities ...